Open AccessVancomycin-resistant enterococcal bacteraemia: is daptomycin as effective as linezolid?
Author(s) -
Vidya Mave,
Julia GarciaDiaz,
T. Islam,
Rodrigo Hasbun
Publication year - 2009
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkp154
Subject(s) - daptomycin , linezolid , vancomycin , enterococcus , medicine , bacteremia , gram positive bacterial infections , vancomycin resistant enterococci , microbiology and biotechnology , antibiotics , intensive care medicine , staphylococcus aureus , biology , bacteria , genetics
The treatment of vancomycin-resistant enterococcal (VRE) bacteraemia remains challenging. Daptomycin is a new antibiotic with bactericidal activity against VRE, but available clinical data are limited.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom